Front Range Clinic INC.
Front Range Clinic INC. was paid $43.73M by Medicaid between Jan 2018 and Dec 2022, across 54 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 20% of everything it billed.
FORT COLLINS, CO 80524
Next to other Addiction Medicine (Family Medicine) Physician providers in Colorado
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 78,769 | $2.99M | |
| 2019 | 484,873 | $11.26M | |
| 2020 | 540,445 | $11.97M | |
| 2021 | 405,582 | $11.42M | |
| 2022 | 53,520 | $6.08M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 105,433 | 55,711 | $8.95M |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 17% | 49,684 | 28,720 | $7.53M |
| J2315 | Injection, naltrexone, depot form, 1 mg | 9.5% | 3,868 | 3,518 | $4.15M |
| 80305 | 3.3% | 128,179 | 64,906 | $1.45M | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.7% | 20,257 | 14,286 | $1.17M |
| 80356 | 2.1% | 58,765 | 36,718 | $903K | |
| 80364 | 2.1% | 58,759 | 36,715 | $903K | |
| 80365 | 2.1% | 58,763 | 36,719 | $903K | |
| 80354 | 2.1% | 58,765 | 36,718 | $903K | |
| 80358 | 2.1% | 58,762 | 36,718 | $903K | |
| 80373 | 2.1% | 58,762 | 36,718 | $903K | |
| 80348 | 2.1% | 58,766 | 36,715 | $903K |
42 more codes
| 80370 | 2.0% | 56,880 | $875K | |
| 80368 | 2.0% | 56,883 | $875K | |
| 80349 | 2.0% | 56,883 | $875K | |
| 80366 | 2.0% | 56,731 | $872K | |
| 80355 | 2.0% | 56,677 | $871K | |
| 80347 | 2.0% | 56,673 | $871K | |
| 80357 | 2.0% | 56,677 | $871K | |
| 80332 | 1.8% | 50,250 | $773K | |
| 80326 | 1.8% | 50,251 | $773K | |
| 80359 | 1.8% | 50,253 | $773K | |
| 80353 | 1.8% | 50,251 | $773K | |
| 80360 | 1.8% | 50,250 | $772K | |
| 80345 | 1.6% | 45,486 | $700K | |
| 80375 | 1.5% | 43,337 | $663K | |
| 99205 | Prolong outpt/office vis | 1.1% | 3,164 | $485K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.1% | 3,876 | $465K |
| 80371 | <1% | 15,432 | $241K | |
| 80372 | <1% | 15,422 | $240K | |
| 80367 | <1% | 15,422 | $240K | |
| 80351 | <1% | 15,383 | $240K | |
| 82075 | <1% | 11,658 | $219K | |
| Q9992 | Injection, buprenorphine extended-release (sublocade), greater than 100 mg | <1% | 128 | $179K |
| 81025 | <1% | 15,289 | $117K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 843 | $98K |
| 99409 | <1% | 1,280 | $71K | |
| 80376 | <1% | 3,987 | $65K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 513 | $50K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 512 | $42K |
| 80321 | <1% | 1,681 | $19K | |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | <1% | 547 | $14K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | <1% | 385 | $9K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 304 | $7K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 75 | $6K |
| H0006 | Alcohol and/or drug services; case management | <1% | 400 | $5K |
| H0001 | Alcohol and/or drug assessment | <1% | 177 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 17 | $231.24 |
| 90686 | <1% | 17 | $215.64 | |
| 96127 | <1% | 12 | $4.24 | |
| 99222 | Initial hospital care, per day, moderate complexity | 0% | 45 | $0.00 |
| 90791 | Psychiatric diagnostic evaluation | 0% | 84 | $0.00 |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 174 | $0.00 |
| 99232 | Hospital visit by a doctor, follow-up day | 0% | 117 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Front Range Clinic INC. | Fort Collins, CO | $3.01M |
| Front Range Clinic INC. | Pueblo, CO | $758K |
| Front Range Clinic INC. | Northglenn, CO | $454K |
| Front Range Clinic INC. | Colorado Springs, CO | $360K |
| Front Range Clinic INC. | Aurora, CO | $324K |
| Front Range Clinic INC. | Greeley, CO | $210K |
| Front Range Clinic INC. | Longmont, CO | $160K |
| Front Range Clinic INC. | Englewood, CO | $95K |
| Front Range Clinic INC. | Boulder, CO | $86K |
| Front Range Clinic INC. | Lakewood, CO | $59K |
| Front Range Clinic INC. | Fort Collins, CO | $40K |
| Front Range Clinic | Steamboat Springs, CO | $25K |
| Front Range Clinic INC. | Loveland, CO | $11K |
| Front Range Clinic INC. | Commerce City, CO | $10K |
| Front Range Clinic INC. | Durango, CO | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.